BB Biotech (0JYO) Financial Statements
BB Biotech Financial Overview
BB Biotech's market cap is currently $2.80B. The company's EPS TTM is $19.51; its P/E ratio is 2.63; and it has a dividend yield of 4.41%. BB Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 76.81M | $ 111.63M | $ 35.00K | $ 4.00K | $ -396.22M |
| Gross Profit | $ 76.76M | $ 111.63M | $ 35.00K | $ 4.00K | $ -396.22M |
| Operating Income | $ 586.83M | $ 84.40M | $ -29.93M | $ -38.62M | $ -52.59M |
| EBITDA | $ 578.64M | $ 80.33M | $ -34.60M | $ -43.01M | $ -59.20M |
| Net Income | $ 578.13M | $ 75.90M | $ -206.61M | $ -357.81M | $ -404.81M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 99.41M | $ 2.41B | $ 2.64B | $ 3.05B | $ 3.64B |
| Total Assets | $ 2.79B | $ 2.41B | $ 2.64B | $ 3.05B | $ 3.64B |
| Total Debt | $ 0.00 | $ 117.50M | $ 304.90M | $ 363.00M | $ 355.00M |
| Net Debt | $ -98.22M | $ 117.04M | $ 304.40M | $ 361.05M | $ 352.17M |
| Total Liabilities | $ 6.97M | $ 121.11M | $ 313.94M | $ 367.25M | $ 355.00M |
| Stockholders' Equity | $ 2.78B | $ 2.29B | $ 2.32B | $ 2.69B | $ 3.28B |
| Cash Flow | |||||
| Free Cash Flow | $ 309.14M | $ 304.56M | $ 218.28M | $ -357.81M | $ -94.79M |
| Operating Cash Flow | $ 309.14M | $ 304.56M | $ 218.28M | $ -357.81M | $ -94.79M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 588.94M | $ 0.00 |
| Financing Cash Flow | $ -203.19M | $ -305.20M | $ -220.21M | $ -233.27M | $ 91.77M |
Currency in CHF